Cardiac Tissue Engineering Market is expected to increase at a compound annual growth rate (CAGR) of 17.5% from 2025 to 2035
The market for cardiac
tissue engineering market is expected to develop at a compound annual
growth rate (CAGR) of 17.5% from 2025 to 2035, from its estimated USD 556.8
million in 2024 to USD 3033.7 million by that time. In order to restore cardiac
health and function, its ultimate goal is to create artificial cardiac tissues
that can fuse with the host's natural heart tissue.
Treating
cardiac disorders including myocardial infarction (MI) and heart failure (HF)
is very challenging because of the adult mammalian heart's limited capacity for
regeneration. To address this obstacle, cardiac tissue engineering aims to
create bioengineered cardiac tissues capable of enhancing or regaining heart
function.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/cardiac-tissue-engineering-market
GROWTH
DRIVERS
One of the
primary factors driving the growth of the cardiac tissue engineering market is
the increasing prevalence of cardiovascular diseases (CVDs), which continue to
be the leading cause of death worldwide. The World Health Organization (WHO)
estimates that cardiovascular diseases (CVDs) account for 17.9 million deaths
globally, or 31% of all deaths. The market for cardiac tissue engineering
technology is being driven by this alarming figure, which emphasizes the urgent
need for innovative therapeutic techniques in heart care.
The goal of
regenerative medicine is to replace or repair damaged organs and tissues, and
it is becoming more and more popular. It works well with cardiac tissue
engineering, which offers state-of-the-art methods for restoring heart function
through the use of scaffolds and artificial tissues. Its demand is also being
driven by the development of biocompatible materials and the growing efficacy
of regenerative therapies.
MARKET
SEGMENTATION:
By Products
-
· Vascular
Grafts
· Cardiac
Patches
· Heart
Valves
By Material
–
· Stem
Cells
o Scaffolds
o Synthetic
Scaffolds
· Biological
Scaffolds
· Collagen-Based
Scaffolds
By
Application –
· Myocardial
Infarction
· Heart
Valve Repair/Replacement
· Congenital
Heart Disease
By End User
–
· Hospitals
& Clinics
· Academic
& Research Institutes
· Other
End Users
By Region -
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East and Africa
Cardiac
Tissue Engineering Market Key Players:
· Artivion,
Inc.
· Terumo
Corporation
· Teijin
Limited
· Medtronic
plc
· Cellular
Logistics
· Elutia
· Baxter
International, Inc.
· Boston
Scientific Corporation
· Other
Key & Niche Players
For More Information about this Report @
https://www.xresearch.biz/shop/cardiac-tissue-engineering-market
About Us: -
xResearch
is a market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment